ArticleScientific reports2026
Role of the AmvAR efflux system on the pathogenesis of Acinetobacter baumannii.
Article in Scientific reports, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
9 authors.
Funding
Abstract
Active extrusion is a key mechanism by which efflux pumps enable nosocomial pathogens to withstand exposure to antimicrobial compounds. In Acinetobacter baumannii, the AmvA efflux pump, belonging to the Major Facilitator Superfamily (MFS) and regulated by the TetR-family repressor AmvR, reduces susceptibility to disinfectants. Here, we investigated the broader functions of the AmvAR system beyond antimicrobial efflux. Our findings demonstrate that, in addition to conferring reduced susceptibility to disinfectants, the AmvAR system regulates the expression of cell surface components linked to pathogenic traits. Specifically, the A. baumannii AmvAR system contributes to motility and cell adhesion, thereby influencing biofilm formation. Loss of either the AmvA efflux pump or its transcriptional regulator AmvR significantly reduced biofilm development. Furthermore, disruption of regulatory control within this system led to a significant upregulation of the csuA pilus gene. Collectively, these results highlight the role of the AmvAR system in the pathogenesis of A. baumannii, underscoring its potential as a therapeutic target.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.